Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-11-21
2006-11-21
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S263400, C544S276000, C544S277000
Reexamination Certificate
active
07138401
ABSTRACT:
2-Aminopurine analogs are described and demonstrated or predicted to have utility as Heat Shock Protein 90 (HSP90) inhibiting agents in the treatment and prevention of various HSP90 mediated disorders, e.g., proliferative disorders. Method of synthesis and use of such compounds are also described and claimed.
REFERENCES:
patent: 4495190 (1985-01-01), Hagberg et al.
patent: 4547573 (1985-10-01), Jung et al.
patent: 4617304 (1986-10-01), Ashton et al.
patent: 4699877 (1987-10-01), Cline et al.
patent: 4748177 (1988-05-01), Sircar et al.
patent: 4772606 (1988-09-01), Sircar et al.
patent: 4774325 (1988-09-01), Casadio et al.
patent: 4806642 (1989-02-01), Sircar et al.
patent: 4918162 (1990-04-01), Slamon et al.
patent: 4921859 (1990-05-01), Sircar et al.
patent: 4968603 (1990-11-01), Slamon et al.
patent: 5002950 (1991-03-01), Malone et al.
patent: 5098906 (1992-03-01), Sircar et al.
patent: 5110818 (1992-05-01), Allgeier et al.
patent: 5204353 (1993-04-01), Meier
patent: 5217866 (1993-06-01), Summerton et al.
patent: 5602156 (1997-02-01), Kohn et al.
patent: 5656629 (1997-08-01), Bacon et al.
patent: 5789394 (1998-08-01), Nguyen-Ba et al.
patent: 5846749 (1998-12-01), Slamon et al.
patent: 5861503 (1999-01-01), Barrio et al.
patent: 5917042 (1999-06-01), Daluge et al.
patent: 5955610 (1999-09-01), Nguyen-Ba et al.
patent: 6005107 (1999-12-01), Nguyen-Ba et al.
patent: 6174875 (2001-01-01), Defranco et al.
patent: 6210974 (2001-04-01), Gold
patent: 6262254 (2001-07-01), Barrio et al.
patent: 6369092 (2002-04-01), Pamukcu
patent: 6444656 (2002-09-01), Nguyen-Ba et al.
patent: 2002/0156277 (2002-10-01), Fick et al.
patent: 2002/0161014 (2002-10-01), Sadhu et al.
patent: 2003/0022864 (2003-01-01), Osjaq et al.
patent: 2003/0078413 (2003-04-01), Dempcy et al.
patent: 2004/0063668 (2004-04-01), Choi et al.
patent: 2004/0097526 (2004-05-01), Gillespie et al.
patent: 2004/0102458 (2004-05-01), Chiosis et al.
patent: 2005/0043239 (2005-02-01), Douangnanya et al.
patent: 2005/0049263 (2005-03-01), Kasibhatla et al.
patent: 2005/0107343 (2005-05-01), Kasibhatla et al.
patent: 2005/0113339 (2005-05-01), Kasibhatla et al.
patent: 2005/0119282 (2005-06-01), Kasibhatla et al.
patent: 2005/0256183 (2005-11-01), Kasibhatla et al.
patent: 55239 (1982-06-01), None
patent: 156559 (1985-10-01), None
patent: 159264 (1985-10-01), None
patent: 0178178 (1986-04-01), None
patent: 0184322 (1986-06-01), None
patent: 206415 (1986-12-01), None
patent: 363320 (1990-04-01), None
patent: 0151528 (1990-07-01), None
patent: 465297 (1992-01-01), None
patent: 502690 (1992-09-01), None
patent: 565377 (1993-10-01), None
patent: 675123 (1995-10-01), None
patent: 10025294 (1988-01-01), None
patent: 06080670 (1994-03-01), None
patent: 08041035 (1996-02-01), None
patent: 08208687 (1996-08-01), None
patent: 09020776 (1997-01-01), None
patent: 09169758 2 (1997-06-01), None
patent: 2000-072773 (2000-03-01), None
patent: 2003-113181 (2003-04-01), None
patent: WO-1986-05518 (1986-09-01), None
patent: WO-1989-10923 (1989-11-01), None
patent: WO-1992-05180 (1992-04-01), None
patent: WO-1995-07695 (1995-03-01), None
patent: WO-1995-08327 (1995-03-01), None
patent: WO-1998-01448 (1998-01-01), None
patent: WO 98/39344 (1998-09-01), None
patent: WO 98/51702 (1998-11-01), None
patent: WO-1999-01454 (1999-01-01), None
patent: WO-1999-02162 (1999-01-01), None
patent: WO-1999-12927 (1999-03-01), None
patent: WO-1999-24432 (1999-05-01), None
patent: WO-1999-32122 (1999-07-01), None
patent: WO 99/51223 (1999-10-01), None
patent: WO 00/06523 (2000-02-01), None
patent: WO-00-43394 (2000-07-01), None
patent: WO-2000-044750 (2000-08-01), None
patent: WO-2000-053394 (2000-09-01), None
patent: WO-2000-068230 (2000-11-01), None
patent: WO-2001-38584 (2001-05-01), None
patent: WO-2001-049688 (2001-07-01), None
patent: WO 01/72779 (2001-10-01), None
patent: WO-2002-085905 (2001-10-01), None
patent: WO-2001-081346 (2001-11-01), None
patent: WO 02/02123 (2002-01-01), None
patent: WO 02/09696 (2002-02-01), None
patent: WO 02/36075 (2002-05-01), None
patent: WO 02/36171 (2002-05-01), None
patent: WO 02/055082 (2002-07-01), None
patent: WO 02/055083 (2002-07-01), None
patent: WO 02/055521 (2002-07-01), None
patent: WO-2002-057288 (2002-07-01), None
patent: WO 02/069900 (2002-09-01), None
patent: WO 02/094196 (2002-11-01), None
patent: WO-2002-088079 (2002-11-01), None
patent: WO-2002-088080 (2002-11-01), None
patent: WO-2002-102314 (2002-12-01), None
patent: WO-2003-000200 (2003-01-01), None
patent: WO-2003-002565 (2003-01-01), None
patent: WO 03/026571 (2003-04-01), None
patent: WO 03/35938 (2003-05-01), None
patent: WO 03/037860 (2003-05-01), None
patent: WO-03-37860 (2003-05-01), None
patent: WO-2003-041643 (2003-05-01), None
patent: WO 03/050295 (2003-06-01), None
patent: WO 03/066005 (2003-08-01), None
patent: WO-2003-106458 (2003-12-01), None
patent: WO-2004-014913 (2004-02-01), None
patent: WO-2004-024082 (2004-03-01), None
patent: WO-2004-029064 (2004-04-01), None
patent: WO-2005-012324 (2005-02-01), None
patent: WO-2005-016348 (2005-02-01), None
patent: WO-2005-016349 (2005-02-01), None
patent: WO-2005-028434 (2005-03-01), None
U.S. Appl. No. 60/128,593, filed Apr. 1999, Rosen et al.
U.S. Appl. No. 60/293,246, filed May 2001, Rosen et al.
U.S. Appl. No. 60/331,893, filed Nov. 2001, Zhang et al.
U.S. Appl. No. 60/335,391, filed Oct. 2001, Kasibhatla et al.
U.S. Appl. No. 60/337,919, filed Nov. 2001, Kasibhatla et al.
U.S. Appl. No. 60/340,762, filed Dec. 2001, Kamal et al.
U.S. Appl. No. 60/359,484, Feb. 2002, Nicchitta et al.
U.S. Appl. 60/371,668, filed Apr. 2002, Ulm et al.
Abblard, J. et al. “Preparation et determination de structure de nouvelles pyridines halogenees Mecanisme de l'halagenation” Bull. Soc. Chim. Fr. 1972, 2466.
Alhede, J. “A Simple and Efficient Synthesis of 9-Substituted Guanines. Cyclodesulfurization of 1-Substituted 5-[(Thiocarbamoyl)amino]imidazole-4-carboxamides under Aqueous Basic Conditions” Org. Chem., 1991, 2139.
Berge et al. “Pharmaceutical Salts”, J. Pharm. Sci. 1977, 66:1-19.
Kanth et al. “Selective Reduction of Carboxylic Acids into Alcohols Using NaBH4 and 12” J. Org. Chem. 1991, 56, 5964-5965.
Blanz, E. J., et al. “Carcinostatic Activity of Thiosemicarbazones of Formyl Heteroaromatic Compounds. VII. 2-Formylpyridine Derivatives Bearing Additional Ring Sustituents” J. Med. Chem. 1970, 13, 1124.
Buchner, J., “Hsp90 & Co.-a holding for folding,” TIBS, Apr. 1999, 24:136-141.
Buchwald, Henry et al. “Long-term, continuous intravenous heparin administration by an implantable infusion pump in ambulatory patients with recurrent venous thrombosis” Surgery, 1980 88, 507.
Bundgaard, A. Ed., Design of Prodrugs, Elseview, 1985 and Method in Enzymology, Widder, K. et al., Ed.; Academic, 1985, vol. 42, p. 309-396.
Bundgaard, H. “Design and Application of Prodrugs” in A Textbook of Drug Design and Development, Krosgaard-Larsen and H. Bundgaard, Ed., 1991, Chapter 5, p. 113-191.
Bundgaard, H., Advanced Drug Delivery.Review, 1992, 8, 1-38.
Burger, Alain et al. “Synthesis of 8-(ö-Hydroxyalkyl)-, 8-(ö-Hydroxyalk-1-enyl)-, and 8-(ö-Hydroxyalk-1-ynyl)adenines Using thetert-Butyldimethylsilyloxymethyl Group, a New and Versatile Protecting Group of Adenine” J. Org. Chem. 2000, 65, 7825-7832.
Caplan A., “Hsp90's secrets unfold: new insights from structural and functional studies,” Trends in Cell Biol., 1999, 9:262-268.
Chiosis et al., “A Small Molecule Designed to Bind to the Adenine Nucleotide Picket of HSP90 Causes HER2 Degradation and the Growth Arrest and Differentiation of Breast Cancer Cells,” Chemistry & Biology, 8, pp. 289-299 (2001).
Chowdhury, Shafinaz F. et al. “Design, Synthesis, and Evaluation of Inhibitors of Trypanosomal and Leishmanial Dihtdrofolate Reductase” J. Med. Chem. 1999, 42, 4300.
Cory, A. et al. “Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture,” Cancer Commun. 1991,
Biamonte Marco A.
Boehm Marcus F.
Hong Kevin D.
Kasibhatla Srinivas Rao
Zhang Lin
Berch Mark L.
Conforma Therapeutics Corporation
Wilson Sonsini Goodrich & Rosati
LandOfFree
2-aminopurine analogs having HSP90-inhibiting activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-aminopurine analogs having HSP90-inhibiting activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-aminopurine analogs having HSP90-inhibiting activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3691978